Data protection Impressum

Technology Park

Neuchâtel-based CCRAFT, a new spin-off from CSEM, has been officially launched as the world’s first production-ready foundry for Thin-Film Lithium Niobate (TFLN) photonic integrated circuits. The company aims to deliver millions of high-performance chips per year to support next-generation optical communication, quantum technologies, and advanced sensing.

CSEM spin-off CCRAFT launches world’s first industrial foundry for TFLN photonic chips

14 May 2025

Swiss Medical Network has become the first healthcare provider in Western Europe to join the prestigious Mayo Clinic Care Network. The collaboration strengthens Switzerland’s position as a hub for advanced medical innovation and international clinical partnerships.

Swiss Medical Network joins Mayo Clinic Care Network to elevate patient care

13 May 2025

Fribourg-based Bloom Biorenewables has raised CHF 13 million in a Series A funding round to advance its proprietary biomass upgrading technology and accelerate market entry.

Bloom Biorenewables raises CHF 13 million to scale renewable materials platform

4 April 2025

The 10th edition of BioInnovation Day gathered more than 250 life sciences stakeholders at Campus Biotech in Geneva. Two standout projects, Artiria Medical and Reverso Therapeutics, were honoured for their innovative contributions to stroke treatment and cardiovascular medicine.

Artiria Medical and Reverso Therapeutics awarded at BioInnovation Day 2025

4 April 2025

The Swiss Battery Technology Center (SBTC) has received international recognition for its pioneering research into automated EV battery recycling, winning first place at the NVIDIA GTC Poster Award 2025 in San Jose.

SBTC’s AI-powered EV battery disassembly research wins top prize at NVIDIA GTC 2025

4 April 2025

Top Stories Western Switzerland

Business environment

Top Stories from Western Switzerland (March 2025)

26 March 2025

Neuchâtel is strengthening its position in the semiconductor industry with a CHF 3 million investment in CSEM’s MEMS manufacturing line.

Neuchâtel launches its own “Chip Act” with CHF 3 million investment in CSEM

4 March 2025

The Swiss Institute of Bioinformatics has inaugurated the Centre for Pathogen Bioinformatics in Bern, a state-of-the-art facility dedicated to strengthening genomic surveillance of infectious diseases.

The Centre for Pathogen Bioinformatics was inaugurated in Bern

4 February 2025

EPFL Innovation Park biotech company AB2 Bio has signed an option and licensing agreement with Japan-based Nippon Shinyaku to advance Tadekinig alfa, a novel treatment for Primary Monogenic IL-18 driven Hyperinflammatory Syndrome. The deal includes up to USD 36 million in early payments and milestone-based funding of up to USD 650 million.

AB2 Bio secures USD 650 million partnership with Nippon Shinyaku for rare disease therapy

27 January 2025

CSEM, in collaboration with Thales Alenia Space and Lisi Aerospace Additive Manufacturing, has created an innovative 3D-printed pipe segment for advanced thermal management systems in satellites.

CSEM develops a 3D-printed thermal control system for satellites

22 January 2025

1 2 3 4 5 6 … 20